Clinical Trials Directory

Trials / Completed

CompletedNCT05140213

A STUDY BEFORE/AFTER THE IMPLEMENTATION OF AN ANTI-INFECTIOUS PRESCRIPTION AID

EVALUATION OF 30-DAY MORTALITY AFTER A VISIT TO THE LAPEYRONIE ADULT EMERGENCY DEPARTMENT OF THE CHU MONTPELLIER FOR SEPSIS OR SEPTIC SHOCK

Status
Completed
Phase
Study type
Observational
Enrollment
371 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Anti-infective strategy is a major public health problem. This is a before-and-after study of an anti-infectious prescription tool with a comparison of mortality at 30 days (then 3 and 6 months) between the two inclusion phases of 6 months each.

Conditions

Interventions

TypeNameDescription
DEVICEAnti-infectious prescription support toolimplementation of a pocket notebook with current anti-infectious recommendations in the emergency department Patients were kept under surveillance for at least one hour before discharge. Patients were discharged home with a 7 day supply of acetaminophen 1000 mg orally every 6 h, ketoprofen 100 mg, orally twice a day, and muscle relaxant as needed. Patients were instructed to take tramadol 50 mg, orally every 6h as needed for low back pain, in case of insufficient relief.

Timeline

Start date
2020-12-12
Primary completion
2021-08-12
Completion
2021-08-30
First posted
2021-12-01
Last updated
2021-12-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05140213. Inclusion in this directory is not an endorsement.

A STUDY BEFORE/AFTER THE IMPLEMENTATION OF AN ANTI-INFECTIOUS PRESCRIPTION AID (NCT05140213) · Clinical Trials Directory